litlas
ログインアカウント作成

Michael H. Davidson

1977–2025 年に発表

別表記
Michael H Davidson
137
論文数
26,572
被引用数
92
h 指数
132
i10 指数

被引用数

Michael H. Davidson の年別被引用数1964 年: 被引用 1 件1976 年: 被引用 2 件1978 年: 被引用 2 件1979 年: 被引用 1 件1981 年: 被引用 1 件1985 年: 被引用 1 件1986 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 1 件1994 年: 被引用 2 件1995 年: 被引用 3 件1996 年: 被引用 14 件1997 年: 被引用 25 件1998 年: 被引用 36 件1999 年: 被引用 35 件2000 年: 被引用 47 件2001 年: 被引用 60 件2002 年: 被引用 66 件2003 年: 被引用 110 件2004 年: 被引用 133 件2005 年: 被引用 137 件2006 年: 被引用 159 件2007 年: 被引用 188 件2008 年: 被引用 259 件2009 年: 被引用 247 件2010 年: 被引用 194 件2011 年: 被引用 278 件2012 年: 被引用 209 件2013 年: 被引用 215 件2014 年: 被引用 203 件2015 年: 被引用 231 件2016 年: 被引用 254 件2017 年: 被引用 192 件2018 年: 被引用 206 件2019 年: 被引用 627 件2020 年: 被引用 631 件2021 年: 被引用 508 件2022 年: 被引用 481 件2023 年: 被引用 387 件2024 年: 被引用 620 件2025 年: 被引用 305 件2026 年: 被引用 17 件1965〜1975 年は被引用が無いため表示していません1977 年は被引用が無いため表示していません1980 年は被引用が無いため表示していません1982〜1984 年は被引用が無いため表示していません1987〜1990 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,717 件、この内訳の 26.1%イギリス: 引用元論文 745 件、この内訳の 7.1%中国: 引用元論文 659 件、この内訳の 6.3%カナダ: 引用元論文 530 件、この内訳の 5.1%イタリア: 引用元論文 481 件、この内訳の 4.6%ドイツ: 引用元論文 433 件、この内訳の 4.2%オーストラリア: 引用元論文 425 件、この内訳の 4.1%オランダ: 引用元論文 376 件、この内訳の 3.6%フランス: 引用元論文 261 件、この内訳の 2.5%日本: 引用元論文 240 件、この内訳の 2.3%スペイン: 引用元論文 237 件、この内訳の 2.3%スウェーデン: 引用元論文 204 件、この内訳の 2%
0%26.1%その他 29.8%

機関

分野

  • Medicine67.8%
  • Biochemistry, Genetics and Molecular Biology13%
  • Nursing10.2%
  • Immunology and Microbiology2.3%
  • Agricultural and Biological Sciences1.7%
  • Neuroscience1%
  • その他4%

トピック

  • Lipoproteins and Cardiovascular Health12.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins7.8%
  • Fatty Acid Research and Health3.6%
  • Cancer, Lipids, and Metabolism3.3%
  • Cholesterol and Lipid Metabolism2.5%
  • Lipid metabolism and disorders1.8%
  • その他68.6%

共著者

全論文

検索で開く
  1. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk

    著者: Stephen J. Nicholls, A. Michael Lincoff, Michelle Garcia, Dianna Bash, Christie M. Ballantyne, Philip J. Barter, Michael H. Davidson, John J.P. Kastelein, Wolfgang Köenig, Darren K. McGuire, Dariush Mozaffarian, Paul M. Ridker, Kausik K. Ray, Brian G. Katona, Anders Himmelmänn, Larrye E. Loss, Martin Rensfeldt, Torbjörn Lundström, Rahul Agrawal, Venu Menon, Kathy Wolski, Steven E. Nissen - JAMA 2020 被引用: 982

  2. Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial

    著者: Stephen J. Nicholls, Marc Ditmarsch, John J.P. Kastelein, Scott P. Rigby, Douglas Kling, Danielle Curcio, Nicholas John, Michael H. Davidson - Nature Medicine 2022 被引用: 169

  3. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease

    著者: Paul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit, Zachary T. Bloomgarden, Vivian Fonseca, Alan J. Garber, George Grunberger, Chris Guerin, David S.H. Bell, Jeffrey I. Mechanick, Rachel Pessah‐Pollack, Kathleen Wyne, Donald A. Smith, Eliot A. Brinton, Sergio Fazio, Michael H. Davidson, Paul S. Jellinger, Yehuda Handelsman, David S.H. Bell, Zachary T. Bloomgarden, Eliot A. Brinton, Michael H. Davidson, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Chris Guerin, Jeffrey I. Mechanick, Rachel Pessah‐Pollack, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne, Michael A. Bush, Farhad Zangeneh, Yehuda Handelsman, David S.H. Bell, Zachary T. Bloomgarden, Eliot A. Brinton, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Chris Guerin, Paul S. Jellinger, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne, Michael H. Davidson - Endocrine Practice 2017 被引用: 1,098

  4. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive Summary

    著者: Yehuda Handelsman, Paul S. Jellinger, Chris Guerin, Zachary T. Bloomgarden, Eliot A. Brinton, Matthew J. Budoff, Michael H. Davidson, Daniel Einhorn, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Ronald M. Krauss, Jeffrey I. Mechanick, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne - Endocrine Practice 2020 被引用: 248

  5. Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial

    著者: Christie M. Ballantyne, Marc Ditmarsch, John J.P. Kastelein, Adam J. Nelson, Douglas Kling, Andrew Hsieh, Danielle Curcio, Kevin C. Maki, Michael H. Davidson, Stephen J. Nicholls - Journal of clinical lipidology 2023 被引用: 81

  6. Partitioning Heritability of Regulatory and Cell-Type-Specific Variants across 11 Common Diseases

    著者: Alexander Gusev, Sang Lee, Gosia Trynka, Hilary K. Finucane, Bjarni J. Vilhjálmsson, Han Xu, Chongzhi Zang, Stephan Ripke, Brendan Bulik‐Sullivan, Eli A. Stahl, Anna K. Kähler, Christina M. Hultman, Shaun Purcell, Steven A. McCarroll, Mark J. Daly, Bogdan Paşaniuc, Patrick F. Sullivan, Benjamin M. Neale, Naomi R. Wray, Soumya Raychaudhuri, Alkes L. Price, Stephan Ripke, Benjamin M. Neale, Aiden Corvin, James Walters, Kai-How Farh, Peter Holmans, Phil Lee, Brendan Bulik‐Sullivan, David Collier, Hailiang Huang, Tune H. Pers, Ingrid Agartz, Esben Agerbo, Margot Albus, Madeline Alexander, Farooq Amin, Silviu‐Alin Bacanu, Martin Begemann, Richard A. Belliveau, Judit Bene, Sarah E. Bergen, Elizabeth Bevilacqua, Tim B. Bigdeli, Donald W. Black, Anders D. Børglum, Richard Bruggeman, Nancy G. Buccola, Randy L. Buckner, William Byerley, Wiepke Cahn, Guiqing Cai, Dominique Campion, Rita M. Cantor, Vaughan J. Carr, Noa Carrera, Stanley V. Catts, Kimberly D. Chambert, Raymond Chan, Ronald Y.L. Chen, Eric Chen, Wei Cheng, Eric Cheung, Siow Ann Chong, C. Robert Cloninger, David Cohen, Nadine Cohen, Paul Cormican, Nick Craddock, James J. Crowley, David Curtis, Michael H. Davidson, Kenneth L. Davis, Franziska Degenhardt, Jurgen Del‐Favero, Lynn E. DeLisi, Ditte Demontis, Dimitris Dikeos, Timothy G. Dinan, Srdjan Djurovic, Gary Donohoe, Elodie Drapeau, Jubao Duan, Frank Dudbridge, Naser Durmishi, Peter Eichhammer, Johan G. Eriksson, Valentina Escott‐Price, Laurent Essioux, Ayman H. Fanous, Martilias S. Farrell, Josef Frank, Lude Franke, Robert Freedman, Nelson B. Freimer, Marion Friedl, Joseph I. Friedman, Menachem Fromer, Giulio Genovese, Lyudmila Georgieva ほか 245 名 - The American Journal of Human Genetics 2014 被引用: 654

  7. Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments

    著者: John J.P. Kastelein, Andrew Hsieh, Mary R. Dicklin, Marc Ditmarsch, Michael H. Davidson - Current Atherosclerosis Reports 2023 被引用: 62

  8. Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels

    著者: Adam J. Nelson, Allan D. Sniderman, Marc Ditmarsch, Mary R. Dicklin, Stephen J. Nicholls, Michael H. Davidson, John J.P. Kastelein - International Journal of Molecular Sciences 2022 被引用: 71

  9. Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region

    著者: Jim Gilbert, Julie Lekstrom-Himes, Debra D. Donaldson, Yih Lee, Mingxiu Hu, Jing Xu, Tim Wyant, Michael H. Davidson - The American Journal of Cardiology 2011 被引用: 181

  10. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety

    著者: Eli M. Roth, Michael H. Davidson - Reviews in Cardiovascular Medicine 2018 被引用: 82

  11. Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio

    著者: Nicholas H. Adamstein, Jan H. Cornel, Michael H. Davidson, Peter Libby, Alessandra De Remigis, Camilla Jensen, Kathrine Ekström, Paul M. Ridker - JAMA Cardiology 2022 被引用: 56

  12. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)

    著者: Peter H. Jones, Michael H. Davidson, Evan A. Stein, Harold Bays, James M. McKenney, Elinor Miller, Valerie A. Cain, James W. Blasetto - The American Journal of Cardiology 2003 被引用: 1,403

  13. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group

    著者: Peter W.F. Wilson, Terry A. Jacobson, Seth S. Martin, Elizabeth J. Jackson, Ngoc‐Anh Le, Michael H. Davidson, Hubert W. Vesper, Ruth Frikke‐Schmidt, Christie M. Ballantyne, Alan T. Remaley - Journal of clinical lipidology 2021 被引用: 134

  14. Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk

    著者: Stephen J. Nicholls, Adam J. Nelson, Marc Ditmarsch, John J.P. Kastelein, Christie M. Ballantyne, Kausik K. Ray, Ann Marie Návar, Steven E. Nissen, Mariko Harada‐Shiba, Danielle Curcio, Annie Neild, Douglas Kling, Andrew Hsieh, Julie Butters, Brian A. Ference, Ulrich Laufs, Maciej Banach, Roxana Mehran, Alberico L. Catapano, Yong Huo, Michael Szarek, Violeta Balinskaite, Michael H. Davidson - New England Journal of Medicine 2025 被引用: 83

  15. Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN

    著者: Stephen J. Nicholls, Adam J. Nelson, Marc Ditmarsch, John J.P. Kastelein, Christie M. Ballantyne, Kausik K. Ray, Ann Marie Návar, Steven E. Nissen, Anne C. Golberg, Liam R. Brunham, Danielle Curcio, Erin Wuerdeman, Annie Neild, Douglas Kling, Andrew Hsieh, Mary R. Dicklin, Brian A. Ference, Ulrich Laufs, Maciej Banach, Roxana Mehran, Alberico L. Catapano, Michael H. Davidson - American Heart Journal 2024 被引用: 44

  16. Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial

    著者: Christopher Farina, Michael H. Davidson, Prediman K. Shah, Charles W. Stark, Wenqi Lu, Cheerag Shirodaria, Timothy Wright, Charalambos Antoniades, Jan Nilsson, Nehal N. Mehta - Cardiovascular Research 2024 被引用: 30

  17. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes

    著者: S. Kodali, Philippe Pîbarot, Pamela S. Douglas, Mathew Williams, Ke Xu, Vinod H. Thourani, Charanjit S. Rihal, Alan Zajarías, Darshan Doshi, Michael H. Davidson, E. Murat Tuzcu, William C. Stewart, Neil J. Weissman, Lars G. Svensson, Kevin L. Greason, Hersh S. Maniar, Michael J. Mack, Saif Anwaruddin, M. B. Leon, Rebecca T. Hahn - European Heart Journal 2014 被引用: 439

  18. Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease

    著者: Robert S. Rosenson, Michael H. Davidson, Benjamin J. Hirsh, Sekar Kathiresan, Daniel Gaudet - Journal of the American College of Cardiology 2014 被引用: 260

  19. Mipomersen, an Apolipoprotein B Synthesis Inhibitor, Reduces Atherogenic Lipoproteins in Patients With Severe Hypercholesterolemia at High Cardiovascular Risk

    著者: Gregory S. Thomas, William C. Cromwell, Shariq Ali, Wai Chin, JoAnn Flaim, Michael H. Davidson - Journal of the American College of Cardiology 2013 被引用: 246

  20. ω-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps

    著者: Kevin C. Maki, Fulya Eren, Martha E Cassens, Mary R. Dicklin, Michael H. Davidson - Advances in Nutrition 2018 被引用: 123

  21. The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study

    著者: Michael H. Davidson, Michael Stevenson, Andrew Hsieh, Zahid Ahmad, Jeanine E. Roeters van Lennep, Caroline Crowson, Joseph L. Witztum - Journal of clinical lipidology 2018 被引用: 83

  22. A method for separating the granulosa cells, the basal lamina and the theca of the preovulatory ovarian follicle of the domestic fowl ( Gallus domesticus )

    著者: A. B. Gilbert, Anthony J. Evans, Margaret M. Perry, Michael H. Davidson - Reproduction 1977 被引用: 388

  23. Safety Considerations with Fibrate Therapy

    著者: Michael H. Davidson, Annemarie Armani, James M. McKenney, Terry A. Jacobson - The American Journal of Cardiology 2006 被引用: 408

  24. Position paper Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

    著者: Maciej Banach, Manfredi Rizzo, Peter P. Tóth, Michel Farnier, Michael H. Davidson, Khalid Al‐Rasadi, Wilbert S. Aronow, Vasilios G. Athyros, Dragan Djurić, М. В. Ежов, Robert S. Greenfield, G. Kees Hovingh, Karam Kostner, Corina Serban, Daniel Lighezan, Zlatko Fras, Patrick M. Moriarty, Paul Muntner, Assen Goudev, R Češka, Stephen J. Nicholls, Marlena Broncel, Dragana Nikolić, Daniel Pella, Raman Puri, Jacek Rysz, Nathan D. Wong, László Bajnok, Steven R. Jones, Kausik K. Ray, Dimitri P. Mikhailidis - Archives of Medical Science 2015 被引用: 385